NXTC – Nextcure Inc
NextCure, Inc.NXTC
$4.89Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $13,086,373.00
EPSttm : -21.24
NextCure, Inc.
$4.89
1.41%$0.07Float Short %
1.36
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-4.24
EPS Last/This Y
5.57
EPS This/Next Y
1.39
Price
4.89
Target Price
25.5
Analyst Recom
1.67
Performance Q
-15.1
Relative Volume
0.3
Beta
1.26
Ticker: NXTC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | NXTC | 0.4358 | N/A | N/A | 0 |
| 2025-07-07 | NXTC | 0.446 | 0.00 | 0.00 | 44 |
| 2025-07-08 | NXTC | 0.4556 | 0.00 | 0.00 | 45 |
| 2025-07-09 | NXTC | 0.46 | 0.00 | 0.00 | 45 |
| 2025-07-10 | NXTC | 0.47 | 0.00 | 0.00 | 45 |
| 2025-07-11 | NXTC | 0.3951 | 0.00 | 0.00 | 45 |
| 2025-07-14 | NXTC | 4.93 | 0.00 | 0.00 | 45 |
| 2025-07-15 | NXTC | 4.86 | 0.00 | 0.00 | 45 |
| 2025-07-16 | NXTC | 4.85 | N/A | N/A | 0 |
| 2025-07-17 | NXTC | 5.35 | N/A | N/A | 0 |
| 2025-07-18 | NXTC | 4.97 | N/A | N/A | 0 |
| 2025-07-21 | NXTC | 4.97 | N/A | N/A | 0 |
| 2025-07-22 | NXTC | 5.16 | N/A | N/A | 0 |
| 2025-07-23 | NXTC | 5.19 | N/A | N/A | 0 |
| 2025-07-24 | NXTC | 5.26 | N/A | N/A | 0 |
| 2025-07-25 | NXTC | 6.23 | N/A | N/A | 0 |
| 2025-07-28 | NXTC | 5.54 | N/A | N/A | 0 |
| 2025-07-29 | NXTC | 5.27 | N/A | N/A | 0 |
| 2025-07-30 | NXTC | 5.01 | N/A | N/A | 0 |
| 2025-07-31 | NXTC | 4.9267 | N/A | N/A | 0 |
| 2025-08-01 | NXTC | 5.08 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | NXTC | 0.44 | 30.0 | - | -1.58 |
| 2025-07-07 | NXTC | 0.44 | 30.0 | - | -1.58 |
| 2025-07-08 | NXTC | 0.46 | 30.0 | - | -1.58 |
| 2025-07-09 | NXTC | 0.45 | 30.0 | - | -1.58 |
| 2025-07-10 | NXTC | 0.47 | 30.0 | - | -1.58 |
| 2025-07-11 | NXTC | 0.40 | 30.0 | - | -1.58 |
| 2025-07-14 | NXTC | 4.90 | 30.0 | 1.0 | -1.58 |
| 2025-07-15 | NXTC | 4.76 | 30.0 | - | -1.58 |
| 2025-07-16 | NXTC | 4.85 | 30.0 | - | -1.58 |
| 2025-07-17 | NXTC | 5.13 | 30.0 | - | -1.58 |
| 2025-07-18 | NXTC | 4.97 | 30.0 | - | -1.58 |
| 2025-07-21 | NXTC | 5.00 | 30.0 | - | -1.58 |
| 2025-07-22 | NXTC | 5.04 | 30.0 | - | -1.58 |
| 2025-07-23 | NXTC | 5.20 | 30.0 | - | -1.58 |
| 2025-07-24 | NXTC | 5.26 | 30.0 | - | -1.58 |
| 2025-07-25 | NXTC | 6.17 | 30.0 | - | -18.31 |
| 2025-07-28 | NXTC | 5.54 | 30.1 | - | -18.31 |
| 2025-07-29 | NXTC | 5.24 | 30.1 | - | -18.31 |
| 2025-07-30 | NXTC | 5.01 | 30.1 | - | -18.31 |
| 2025-07-31 | NXTC | 4.96 | 30.1 | - | -18.31 |
| 2025-08-01 | NXTC | 4.89 | 30.1 | - | -18.31 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | NXTC | 0.00 | -7.22 | 1.22 |
| 2025-07-07 | NXTC | 0.00 | -7.22 | 1.22 |
| 2025-07-08 | NXTC | 0.00 | -7.22 | 1.22 |
| 2025-07-09 | NXTC | 0.00 | -7.22 | 1.22 |
| 2025-07-10 | NXTC | 0.00 | -7.22 | 1.22 |
| 2025-07-11 | NXTC | 0.00 | -7.22 | 1.40 |
| 2025-07-14 | NXTC | 0.00 | -7.27 | 1.40 |
| 2025-07-15 | NXTC | 0.00 | -7.27 | 1.40 |
| 2025-07-16 | NXTC | 0.00 | -7.27 | 1.40 |
| 2025-07-17 | NXTC | 0.00 | -7.27 | 1.40 |
| 2025-07-18 | NXTC | 0.00 | -7.27 | 1.40 |
| 2025-07-21 | NXTC | 0.00 | 0 | 14.64 |
| 2025-07-22 | NXTC | 0.00 | 0 | 14.64 |
| 2025-07-23 | NXTC | 0.00 | 0 | 14.64 |
| 2025-07-24 | NXTC | 0.00 | 0 | 14.64 |
| 2025-07-25 | NXTC | 0.00 | 0 | 1.36 |
| 2025-07-28 | NXTC | 0.00 | 0 | 1.36 |
| 2025-07-29 | NXTC | 0.00 | 0 | 1.36 |
| 2025-07-30 | NXTC | 0.00 | 0 | 1.36 |
| 2025-07-31 | NXTC | 0.00 | 0 | 1.36 |
| 2025-08-01 | NXTC | 0.00 | 0 | 1.36 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.39
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-4.63
Insider Transactions
Institutional Transactions
Beta
1.26
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
5
Growth Score
19
Sentiment Score
27
Actual DrawDown %
84.1
Max Drawdown 5-Year %
Target Price
25.5
P/E
Forward P/E
PEG
P/S
P/B
0.2
P/Free Cash Flow
EPS
-21.23
Average EPS Est. Cur. Y
-18.31
EPS Next Y. (Est.)
-16.92
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.3
Return on Equity vs Sector %
-112.4
Return on Equity vs Industry %
-93.8
EPS 1 7Days Diff
0.7
EPS 1 30Days Diff
0.71
EBIT Estimation
NextCure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading